Werewolf Therapeutics, Inc. (HOWL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -10.6M | -11.02M | -15.16M | -15.16M | -18.95M | -14.25M | -12.46M | -14.18M | -15.3M | -4.58M | -7.21M | -10.92M |
| Operating CF Margin % | - | - | - | - | - | - | - | -1240.33% | -2061.59% | -305.46% | -122.23% | -135.14% |
| Operating CF Growth % | 44.07% | 22.65% | -21.62% | -6.96% | -23.87% | -210.84% | -72.89% | -29.81% | -54.55% | 61.37% | 50.19% | -3504.29% |
| Net Income | -13.53M | -8.38M | -16.37M | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M |
| Depreciation & Amortization | 398K | 400K | 402K | 406K | 426K | 442K | 454K | 454K | 464K | 460K | 445K | 434K |
| Stock-Based Compensation | 0 | 1.21M | 0 | 1.79M | 2.01M | 1.91M | 2.01M | 2.6M | 2.31M | 1.87M | 2.1M | 1.93M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.81M | -3.11M | 0 |
| Other Non-Cash Items | 1.07M | -1.07M | 752K | 694K | -2.86M | 3.34M | 1.37M | 978K | 468K | 3.26M | 3.74M | 409K |
| Working Capital Changes | 1.47M | -3.19M | 60K | -75K | -432K | 458K | 380K | -962K | -2.34M | 4.63M | -2.09M | -8.6M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 464K | 81K | 230K | 575K | 4.56M | 1.02M | -672K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 672K |
| Change in Payables | 1.92M | -3.94M | 0 | 1.02M | 0 | 0 | 0 | 0 | -2.47M | -4.58M | -104K | -616K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | -123K | -3K | -17K | -111K | -198K | -221K | -182K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -123K | -3K | -17K | -111K | -198K | -221K | -182K |
| CapEx % of Revenue | - | - | - | - | - | - | - | 1.49% | 14.96% | 13.19% | 3.75% | 2.25% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 2.37M | 3.27M | 388K | 0 | 2.55M | -6K | -9.72M | 20.26M | 9.07M | 41K | 692K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 2.37M | 0 | 388K | 0 | 0 | -6K | 0 | 20.25M | 8.88M | 182K | 642K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -6K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 3.27M | 0 | 0 | 2.55M | 0 | -9.72M | 12K | 191K | -141K | 50K |
| Net Change in Cash | -10.6M | -8.66M | -11.88M | -14.78M | -18.95M | -11.83M | -12.47M | -23.91M | 4.85M | 4.08M | -7.18M | -10.41M |
| Free Cash Flow | -10.6M | -11.02M | -15.16M | -15.16M | -18.95M | -14.38M | -12.46M | -14.19M | -15.41M | -4.78M | -7.43M | -11.1M |
| FCF Margin % | - | - | - | - | - | - | - | -1241.82% | -2076.55% | -318.65% | -125.98% | -137.4% |
| FCF Growth % | 44.07% | 23.31% | -21.59% | -6.83% | -22.98% | -200.54% | -67.79% | -27.84% | -53.07% | 61.39% | 54.77% | -685.22% |
| FCF per Share | -0.21 | -0.24 | -0.33 | -0.34 | -0.42 | -0.32 | -0.29 | -0.33 | -0.37 | -0.13 | -0.21 | -0.31 |
| FCF Conversion (FCF/Net Income) | 0.78x | 1.32x | 0.93x | 0.84x | 1.05x | 0.70x | 0.75x | 0.82x | 0.94x | 0.38x | 0.87x | 2.14x |
| Interest Paid | 0 | 0 | 790K | 0 | 773K | 781K | 789K | 878K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |